(Q38206587)

31 August 2017

The therapeutic potential of targeting the epithelial-mesenchymal transition in cancer (English)

1 reference

31 August 2017

2

1 reference

31 August 2017

3

Fazlul H Sarkar

1 reference

31 August 2017

Kevin R Ginnebaugh

1

1 reference

PubMed ID

24758643

31 August 2017

language of work or name

English

0 references

publication date

23 April 2014

1 reference

Expert Opinion on Therapeutic Targets

31 August 2017

1 reference

31 August 2017

18

1 reference

31 August 2017

7

1 reference

31 August 2017

731-745

1 reference

Epithelial-mesenchymal transitions in development and pathologies

31 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

The Snail genes as inducers of cell movement and survival: implications in development and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

The ins and outs of the epithelial to mesenchymal transition in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

FGF receptors: cancer biology and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Cancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Novel strategies targeting cancer stem cells through phytochemicals and their analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Norcantharidin, derivative of cantharidin, for cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

21 January 2018

Breast cancer stem cells

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Stem cell-like side populations in esophageal cancer: a source of chemotherapy resistance and metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Epithelial-to-mesenchymal transition: what is the impact on breast cancer stem cells and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Colon cancer stem cells: implications in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Ovarian cancer stem cell markers: prognostic and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

CD133: a cancer stem cells marker, is used in colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

The epithelial-mesenchymal transition generates cells with properties of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Generation of breast cancer stem cells through epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Identification of selective inhibitors of cancer stem cells by high-throughput screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Epithelial-to-mesenchymal transition and stem cells in endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Enrichment of ovarian cancer stem-like cells is associated with epithelial to mesenchymal transition through an miRNA-activated AKT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Interplay of Stem Cell Characteristics, EMT, and Microtentacles in Circulating Breast Tumor Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Downregulation of miR-200a induces EMT phenotypes and CSC-like signatures through targeting the β-catenin pathway in hepatic oval cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Brief report: The lincRNA Hotair is required for epithelial-to-mesenchymal transition and stemness maintenance of cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Regulatory networks defining EMT during cancer initiation and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

The role of epithelial-mesenchymal transition programming in invasion and metastasis: a clinical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

The role of epithelial-mesenchymal transition in cancer pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Epithelial-mesenchymal transition in cancer development and its clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Epithelial-mesenchymal transition: a hallmark in metastasis formation linking circulating tumor cells and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Sox4, EMT programs, and the metastatic progression of breast cancers: mastering the masters of EMT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Epithelial-mesenchymal plasticity in carcinoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Notch signaling activated by replication stress-induced expression of midkine drives epithelial-mesenchymal transition and chemoresistance in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Notch signaling mediates TGF-β1-induced epithelial-mesenchymal transition through the induction of Snai1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Hypoxia-induced down-regulation of microRNA-34a promotes EMT by targeting the Notch signaling pathway in tubular epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Rhamnetin and cirsiliol induce radiosensitization and inhibition of epithelial-mesenchymal transition (EMT) by miR-34a-mediated suppression of Notch-1 expression in non-small cell lung cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Regulation of EMT by Notch signaling pathway in tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

HMGA2 elicits EMT by activating the Wnt/β-catenin pathway in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

SOX2 promotes tumor metastasis by stimulating epithelial-to-mesenchymal transition via regulation of WNT/β-catenin signal network

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

β-Catenin activation contributes to the pathogenesis of adenomyosis through epithelial-mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

A double-negative feedback loop between Wnt-β-catenin signaling and HNF4α regulates epithelial-mesenchymal transition in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Erb-041, an estrogen receptor-β agonist, inhibits skin photocarcinogenesis in SKH-1 hairless mice by downregulating the WNT signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Akt/PKB-mediated phosphorylation of Twist1 promotes tumor metastasis via mediating cross-talk between PI3K/Akt and TGF-β signaling axes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

TACC3 promotes epithelial-mesenchymal transition (EMT) through the activation of PI3K/Akt and ERK signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Selenate induces epithelial-mesenchymal transition in a colorectal carcinoma cell line by AKT activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Targeted regulation of PI3K/Akt/mTOR/NF-κB signaling by indole compounds and their derivatives: mechanistic details and biological implications for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Deregulation of PI3K/Akt/mTOR signaling pathways by isoflavones and its implication in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Par-4 downregulation confers cisplatin resistance in pancreatic cancer cells via PI3K/Akt pathway-dependent EMT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Altered death receptor signaling promotes epithelial-to-mesenchymal transition and acquired chemoresistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Molecular markers of epithelial-to-mesenchymal transition are associated with tumor aggressiveness in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Epithelial-mesenchymal transition with expression of SNAI1-induced chemoresistance in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Role of crosstalk between interleukin-6 and transforming growth factor-beta 1 in epithelial-mesenchymal transition and chemoresistance in biliary tract cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

SNAI1-mediated epithelial-mesenchymal transition confers chemoresistance and cellular plasticity by regulating genes involved in cell death and stem cell maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Chemotherapy with Erlotinib or chemotherapy alone in advanced non-small cell lung cancer with acquired resistance to EGFR tyrosine kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Acquisition of EMT phenotype in the gefitinib-resistant cells of a head and neck squamous cell carcinoma cell line through Akt/GSK-3β/snail signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Acquisition of epithelial-mesenchymal transition phenotype and cancer stem cell-like properties in cisplatin-resistant lung cancer cells through AKT/β-catenin/Snail signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Chemoresistance to 5-fluorouracil induces epithelial-mesenchymal transition via up-regulation of Snail in MCF7 human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Retracted: Up-Regulation of Sonic Hedgehog Contributes to TGF-β1-Induced Epithelial to Mesenchymal Transition in NSCLC Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Inhibition of Hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Chemoresistance to gemcitabine in hepatoma cells induces epithelial-mesenchymal transition and involves activation of PDGF-D pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Notch3 induces epithelial-mesenchymal transition and attenuates carboplatin-induced apoptosis in ovarian cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Metformin reverses multidrug resistance and epithelial-mesenchymal transition (EMT) via activating AMP-activated protein kinase (AMPK) in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

N1-guanyl-1,7-diaminoheptane sensitizes bladder cancer cells to doxorubicin by preventing epithelial-mesenchymal transition through inhibition of eukaryotic translation initiation factor 5A2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Targeting epithelial-to-mesenchymal transition with Met inhibitors reverts chemoresistance in small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Short interfering RNA directed against TWIST, a novel zinc finger transcription factor, increases A549 cell sensitivity to cisplatin via MAPK/mitochondrial pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Knockdown of Snail, a novel zinc finger transcription factor, via RNA interference increases A549 cell sensitivity to cisplatin via JNK/mitochondrial pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Inhibition of ZEB1 reverses EMT and chemoresistance in docetaxel-resistant human lung adenocarcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Hypoxia-induced Jagged2 promotes breast cancer metastasis and self-renewal of cancer stem-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Differential regulation of Snail by hypoxia and hyperglycemia in human proximal tubule cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Notch signaling mediates hypoxia-induced tumor cell migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Significance and prognostic value of Gli-1 and Snail/E-cadherin expression in progressive gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Epithelial mesenchymal transition and pancreatic tumor initiating CD44+/EpCAM+ cells are inhibited by γ-secretase inhibitor IX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Therapeutic approaches to modulating Notch signaling: current challenges and future prospects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Wnt/beta-catenin signaling: components, mechanisms, and diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

CK2 inhibitor CX-4945 blocks TGF-β1-induced epithelial-to-mesenchymal transition in A549 human lung adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Activity of the clinical-stage CK2-specific inhibitor CX-4945 against chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Garcinol regulates EMT and Wnt signaling pathways in vitro and in vivo, leading to anticancer activity against breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

The PI3K/Akt/mTOR signaling pathway mediates insulin-like growth factor 1-induced E-cadherin down-regulation and cell proliferation in ovarian cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Stabilization of Snail through AKT/GSK-3β signaling pathway is required for TNF-α-induced epithelial-mesenchymal transition in prostate cancer PC3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Regulation of Akt/FOXO3a/GSK-3beta/AR signaling network by isoflavone in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

The twist box domain is required for Twist1-induced prostate cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Concomitant targeting of multiple key transcription factors effectively disrupts cancer stem cells enriched in side population of human pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Efficient induction of pluripotent stem cells from granulosa cells by Oct4 and Sox2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Embryonic stem cells markers SOX2, OCT4 and Nanog expression and their correlations with epithelial-mesenchymal transition in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

The role of microRNAs in breast cancer migration, invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

The role of cancer stem cells and miRNAs in defining the complexities of brain metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Targeting MicroRNAs for personalized cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Review of miR-200b and cancer chemosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Lin28 mediates radiation resistance of breast cancer cells via regulation of caspase, H2A.X and Let-7 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Meta-analysis of transcriptome reveals let-7b as an unfavorable prognostic biomarker and predicts molecular and clinical subclasses in high-grade serous ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Differential processing of let-7a precursors influences RRM2 expression and chemosensitivity in pancreatic cancer: role of LIN-28 and SET oncoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

A novel network integrating a miRNA-203/SNAI1 feedback loop which regulates epithelial to mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Signaling between transforming growth factor β (TGF-β) and transcription factor SNAI2 represses expression of microRNA miR-203 to promote epithelial-mesenchymal transition and tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.909807

10.1517/14728222.2014.909807

21 January 2018

Identifiers

DOI

1 reference

31 August 2017

1 reference

PubMed ID

24758643